论文部分内容阅读
目的观察阿托伐他汀联合辅酶Q10治疗对冠心病早期心功能减退患者心功能的影响。方法 70例冠心病早期心功能减退患者,根据入院时间不同分为观察组与对照组,各35例。对照组予以单一阿托伐他汀治疗,观察组在对照组的基础上联合辅酶Q10治疗,对两组患者的体质量指数、血压、心率及心功能指标进行观察比较。结果治疗后两组患者心功能指标均得到一定改善,而观察组患者心功能指标改善幅度优于对照组(P<0.05);两组患者体质量指数、血压、心率指标比较差异无统计学意义(P>0.05)。结论阿托伐他汀联合辅酶Q10治疗冠心病早期心功能减退疗效理想,有效改善心功能,明显优于单一阿托伐他汀治疗,值得临床推广与应用。
Objective To observe the effects of atorvastatin combined with coenzyme Q10 on cardiac function in patients with early hypothyroidism. Methods 70 patients with early cardiac dysfunction in patients with coronary heart disease were divided into observation group and control group according to the different admission time, 35 cases in each group. The control group was treated with atorvastatin alone. The observation group was treated with coenzyme Q10 on the basis of the control group. Body mass index, blood pressure, heart rate and cardiac function were compared between the two groups. Results After treatment, the cardiac function indexes of both groups were improved, while the observation group had better improvement of cardiac function index than the control group (P <0.05). There was no significant difference in body mass index, blood pressure and heart rate between the two groups (P> 0.05). Conclusions Atorvastatin combined with coenzyme Q10 in the treatment of early cardiac dysfunction in patients with coronary heart disease is effective and effective in improving cardiac function. It is superior to single atorvastatin treatment and is worthy of clinical promotion and application.